Calumet (CLMT) to Release Quarterly Earnings on Friday

Key Points

• Calumet (CLMT) is set to release its Q2 2025 earnings on August 8th, with expectations of a loss of ($0.42) per share and revenue of $982.88 million.
• The company reported a previous quarterly EPS of ($1.03), missing estimates by ($0.62), while revenue was down 1.2% year over year.
• Calumet stock has seen recent insider activity with significant sales, including 100,000 shares sold by Director Jennifer Straumins at an average price of $13.17.

Calumet (NASDAQ:CLMT - Get Free Report) is anticipated to announce its Q2 2025 earnings results before the market opens on Friday, August 8th. Analysts expect the company to announce earnings of ($0.42) per share and revenue of $982.88 million for the quarter.

Calumet (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The business had revenue of $993.90 million during the quarter, compared to analysts' expectations of $899.62 million. During the same quarter in the previous year, the business posted ($0.51) EPS. Calumet's revenue for the quarter was down 1.2% on a year-over-year basis. On average, analysts expect Calumet to post $-3 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Calumet Price Performance

Shares of NASDAQ CLMT traded down $0.43 during mid-day trading on Friday, hitting $15.51. 640,136 shares of the stock traded hands, compared to its average volume of 667,580. The company has a market cap of $1.34 billion, a PE ratio of -3.88 and a beta of 0.91. Calumet has a twelve month low of $7.68 and a twelve month high of $25.29. The firm has a 50 day simple moving average of $15.60 and a two-hundred day simple moving average of $14.11.

Wall Street Analysts Forecast Growth

CLMT has been the topic of a number of research analyst reports. Wells Fargo & Company cut their target price on Calumet from $23.00 to $21.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Bank of America began coverage on Calumet in a research report on Tuesday, May 13th. They issued a "buy" rating and a $15.00 price objective on the stock. Finally, The Goldman Sachs Group lowered their price objective on Calumet from $16.00 to $14.00 and set a "buy" rating on the stock in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $18.50.

Insider Buying and Selling

In other Calumet news, SVP Gregory J. Morical sold 25,123 shares of the firm's stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $16.69, for a total transaction of $419,302.87. Following the completion of the transaction, the senior vice president owned 39,415 shares of the company's stock, valued at approximately $657,836.35. This trade represents a 38.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jennifer Straumins sold 100,000 shares of Calumet stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $13.17, for a total transaction of $1,317,000.00. Following the completion of the sale, the director directly owned 1,084,589 shares of the company's stock, valued at approximately $14,284,037.13. This trade represents a 8.44% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 275,123 shares of company stock valued at $4,113,303 in the last ninety days. Insiders own 4.07% of the company's stock.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.